A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS). / Riazi, Afsane; Porter, Bernadette; Chataway, Jeremy; Thompson, Alan; Hobart, Jeremy.

In: Health and Quality of Life Outcomes, Vol. 9, No. 80, 2011.

Research output: Contribution to journalArticlepeer-review

Published

Standard

A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS). / Riazi, Afsane; Porter, Bernadette; Chataway, Jeremy; Thompson, Alan; Hobart, Jeremy.

In: Health and Quality of Life Outcomes, Vol. 9, No. 80, 2011.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Author

Riazi, Afsane ; Porter, Bernadette ; Chataway, Jeremy ; Thompson, Alan ; Hobart, Jeremy. / A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS). In: Health and Quality of Life Outcomes. 2011 ; Vol. 9, No. 80.

BibTeX

@article{0b155a25520e42d9b24be2a2bf5db479,
title = "A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS)",
author = "Afsane Riazi and Bernadette Porter and Jeremy Chataway and Alan Thompson and Jeremy Hobart",
year = "2011",
doi = "10.1186/1477-7525-9-80",
language = "English",
volume = "9",
journal = "Health and Quality of Life Outcomes",
issn = "1477-7525",
publisher = "BioMed Central",
number = "80",

}

RIS

TY - JOUR

T1 - A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS)

AU - Riazi, Afsane

AU - Porter, Bernadette

AU - Chataway, Jeremy

AU - Thompson, Alan

AU - Hobart, Jeremy

PY - 2011

Y1 - 2011

U2 - 10.1186/1477-7525-9-80

DO - 10.1186/1477-7525-9-80

M3 - Article

VL - 9

JO - Health and Quality of Life Outcomes

JF - Health and Quality of Life Outcomes

SN - 1477-7525

IS - 80

ER -